Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History QDEL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics QDEL

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Quidel Corporation

QDEL
Current price
29.22 USD -0.5 USD (-1.68%)
Last closed 30.19 USD
ISIN US74838J1016
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 2 041 626 112 USD
Yield for 12 month -3.75 %
1Y
3Y
5Y
10Y
15Y
QDEL
21.11.2021 - 28.11.2021

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California. Address: 9975 Summers Ridge Road, San Diego, CA, United States, 92121

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

47.14 USD

P/E Ratio

Dividend Yield

Financials QDEL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures QDEL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+2 782 900 000 USD

Last Year

+2 993 500 000 USD

Current Quarter

+692 800 000 USD

Last Quarter

+707 800 000 USD

Current Year

+1 286 500 000 USD

Last Year

+1 283 400 000 USD

Current Quarter

+644 800 000 USD

Last Quarter

+326 100 000 USD
EBITDA 560 700 032 USD
Operating Margin TTM 7.03 %
Price to Earnings
Return On Assets TTM 1.12 %
PEG Ratio 7.19
Return On Equity TTM -11.38 %
Wall Street Target Price 47.14 USD
Revenue TTM 2 764 699 904 USD
Book Value 44.40 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -2.60 %
Dividend Yield
Gross Profit TTM 1 297 699 968 USD
Earnings per share -5.23 USD
Diluted Eps TTM -5.23 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -77.10 %
Profit Margin -12.97 %

Stock Valuation QDEL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 12.36
Enterprise Value Revenue 1.67
Price Sales TTM 0.74
Enterprise Value EBITDA 15.97
Price Book MRQ 0.68

Technical Indicators QDEL

For 52 Weeks

23.77 USD 49.45 USD
50 Day MA 30.08 USD
Shares Short Prior Month 3 909 746
200 Day MA 37.44 USD
Short Ratio 3.55
Shares Short 4 065 000
Short Percent 10.01 %